240 related articles for article (PubMed ID: 21467215)
1. HLA-DR-presented peptide repertoires derived from human monocyte-derived dendritic cells pulsed with blood coagulation factor VIII.
van Haren SD; Herczenik E; ten Brinke A; Mertens K; Voorberg J; Meijer AB
Mol Cell Proteomics; 2011 Jun; 10(6):M110.002246. PubMed ID: 21467215
[TBL] [Abstract][Full Text] [Related]
2. Limited promiscuity of HLA-DRB1 presented peptides derived of blood coagulation factor VIII.
van Haren SD; Wroblewska A; Herczenik E; Kaijen PH; Ruminska A; ten Brinke A; Meijer AB; Voorberg J
PLoS One; 2013; 8(11):e80239. PubMed ID: 24244658
[TBL] [Abstract][Full Text] [Related]
3. Comparative profiling of HLA-DR and HLA-DQ associated factor VIII peptides presented by monocyte-derived dendritic cells.
Peyron I; Hartholt RB; Pedró-Cos L; van Alphen F; Brinke AT; Lardy N; Meijer AB; Voorberg J
Haematologica; 2018 Jan; 103(1):172-178. PubMed ID: 29025906
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the HLA-DR peptidome from human dendritic cells reveals high affinity repertoires and nonconventional pathways of peptide generation.
Ciudad MT; Sorvillo N; van Alphen FP; Catalán D; Meijer AB; Voorberg J; Jaraquemada D
J Leukoc Biol; 2017 Jan; 101(1):15-27. PubMed ID: 27365532
[TBL] [Abstract][Full Text] [Related]
5. Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products.
Jankowski W; Park Y; McGill J; Maraskovsky E; Hofmann M; Diego VP; Luu BW; Howard TE; Kellerman R; Key NS; Sauna ZE
Blood Adv; 2019 May; 3(9):1429-1440. PubMed ID: 31053570
[TBL] [Abstract][Full Text] [Related]
6. CD4+ T-cell epitopes associated with antibody responses after intravenously and subcutaneously applied human FVIII in humanized hemophilic E17 HLA-DRB1*1501 mice.
Steinitz KN; van Helden PM; Binder B; Wraith DC; Unterthurner S; Hermann C; Schuster M; Ahmad RU; Weiller M; Lubich C; de la Rosa M; Schwarz HP; Reipert BM
Blood; 2012 Apr; 119(17):4073-82. PubMed ID: 22394599
[TBL] [Abstract][Full Text] [Related]
7. von Willebrand factor binds to the surface of dendritic cells and modulates peptide presentation of factor VIII.
Sorvillo N; Hartholt RB; Bloem E; Sedek M; ten Brinke A; van der Zwaan C; van Alphen FP; Meijer AB; Voorberg J
Haematologica; 2016 Mar; 101(3):309-18. PubMed ID: 26635035
[TBL] [Abstract][Full Text] [Related]
8. One NY-ESO-1-derived epitope that promiscuously binds to multiple HLA-DR and HLA-DP4 molecules and stimulates autologous CD4+ T cells from patients with NY-ESO-1-expressing melanoma.
Mandic M; Castelli F; Janjic B; Almunia C; Andrade P; Gillet D; Brusic V; Kirkwood JM; Maillere B; Zarour HM
J Immunol; 2005 Feb; 174(3):1751-9. PubMed ID: 15661941
[TBL] [Abstract][Full Text] [Related]
9. Identification and removal of a promiscuous CD4+ T cell epitope from the C1 domain of factor VIII.
Jones TD; Phillips WJ; Smith BJ; Bamford CA; Nayee PD; Baglin TP; Gaston JS; Baker MP
J Thromb Haemost; 2005 May; 3(5):991-1000. PubMed ID: 15869596
[TBL] [Abstract][Full Text] [Related]
10. Major histocompatibility complex class II+ invariant chain negative breast cancer cells present unique peptides that activate tumor-specific T cells from breast cancer patients.
Chornoguz O; Gapeev A; O'Neill MC; Ostrand-Rosenberg S
Mol Cell Proteomics; 2012 Nov; 11(11):1457-67. PubMed ID: 22942358
[TBL] [Abstract][Full Text] [Related]
11. Class II MHC self-antigen presentation in human B and T lymphocytes.
Costantino CM; Spooner E; Ploegh HL; Hafler DA
PLoS One; 2012; 7(1):e29805. PubMed ID: 22299025
[TBL] [Abstract][Full Text] [Related]
12. Hunting down factor VIII in the immunopeptidome.
Hartholt RB; Peyron I; Voorberg J
Cell Immunol; 2016 Mar; 301():59-64. PubMed ID: 26610639
[TBL] [Abstract][Full Text] [Related]
13. CD9 Regulates Major Histocompatibility Complex Class II Trafficking in Monocyte-Derived Dendritic Cells.
Rocha-Perugini V; Martínez Del Hoyo G; González-Granado JM; Ramírez-Huesca M; Zorita V; Rubinstein E; Boucheix C; Sánchez-Madrid F
Mol Cell Biol; 2017 Aug; 37(15):. PubMed ID: 28533221
[TBL] [Abstract][Full Text] [Related]
14. Quantitative HLA-class-II/factor VIII (FVIII) peptidomic variation in dendritic cells correlates with the immunogenic potential of therapeutic FVIII proteins in hemophilia A.
Diego VP; Luu BW; Hofmann M; Dinh LV; Almeida M; Powell JS; Rajalingam R; Peralta JM; Kumar S; Curran JE; Sauna ZE; Kellerman R; Park Y; Key NS; Escobar MA; Huynh H; Verhagen AM; Williams-Blangero S; Lehmann PV; Maraskovsky E; Blangero J; Howard TE
J Thromb Haemost; 2020 Jan; 18(1):201-216. PubMed ID: 31556206
[TBL] [Abstract][Full Text] [Related]
15. Preferential HLA-DRB1*11-dependent presentation of CUB2-derived peptides by ADAMTS13-pulsed dendritic cells.
Sorvillo N; van Haren SD; Kaijen PH; ten Brinke A; Fijnheer R; Meijer AB; Voorberg J
Blood; 2013 Apr; 121(17):3502-10. PubMed ID: 23372163
[TBL] [Abstract][Full Text] [Related]
16. Differential capacity of T cell priming in naive donors of promiscuous CD4+ T cell epitopes of HCV NS3 and Core proteins.
Castelli FA; Leleu M; Pouvelle-Moratille S; Farci S; Zarour HM; Andrieu M; Auriault C; Ménez A; Georges B; Maillere B
Eur J Immunol; 2007 Jun; 37(6):1513-23. PubMed ID: 17492804
[TBL] [Abstract][Full Text] [Related]
17. Modulating the microenvironment during FVIII uptake influences the nature of FVIII-peptides presented by antigen-presenting cells.
Lubich C; Steinitz KN; Hoelbl B; Prenninger T; van Helden PM; Weiller M; Reipert BM
Front Immunol; 2022; 13():975680. PubMed ID: 36389737
[TBL] [Abstract][Full Text] [Related]
18. Identification of MHC class II restricted T-cell-mediated reactivity against MHC class I binding Mycobacterium tuberculosis peptides.
Wang M; Tang ST; Stryhn A; Justesen S; Larsen MV; Dziegiel MH; Lewinsohn DM; Buus S; Lund O; Claesson MH
Immunology; 2011 Apr; 132(4):482-91. PubMed ID: 21294723
[TBL] [Abstract][Full Text] [Related]
19. The signal peptide of the tumor-shared antigen midkine hosts CD4+ T cell epitopes.
Kerzerho J; Schneider A; Favry E; Castelli FA; Maillère B
J Biol Chem; 2013 May; 288(19):13370-7. PubMed ID: 23553629
[TBL] [Abstract][Full Text] [Related]
20. Identification of multiple HLA-DR-restricted epitopes of the tumor-associated antigen CAMEL by CD4+ Th1/Th2 lymphocytes.
Slager EH; van der Minne CE; Krüse M; Krueger DD; Griffioen M; Osanto S
J Immunol; 2004 Apr; 172(8):5095-102. PubMed ID: 15067093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]